Atlas Trials

Fruquintinib in the Cross-line Treatment of Refractory mCRC

Clinical trial NCT06099314 · UNKNOWN

Trial details

NCT number
NCT06099314
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status
UNKNOWN
Study type
OBSERVATIONAL
FruquintinibMetastatic Colorectal Cancer
Start date
2023-10-01
Primary completion
2025-09-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.